Filing Details

Accession Number:
0001022079-22-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-25 16:31:18
Reporting Period:
2022-05-23
Accepted Time:
2022-05-25 16:31:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1142624 H Stephen Rusckowski 500 Plaza Drive
Secaucus NJ 07094
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-23 34,898 $103.57 369,731 No 4 M Direct
Common Stock Disposition 2022-05-23 33,898 $140.12 335,833 No 4 S Direct
Common Stock Disposition 2022-05-23 800 $141.54 335,033 No 4 S Direct
Common Stock Disposition 2022-05-23 200 $142.26 334,833 No 4 S Direct
Common Stock Acquisiton 2022-05-23 42,568 $86.63 377,401 No 4 M Direct
Common Stock Disposition 2022-05-23 41,268 $140.12 336,133 No 4 S Direct
Common Stock Disposition 2022-05-23 1,000 $141.51 335,133 No 4 S Direct
Common Stock Disposition 2022-05-23 300 $142.24 334,833 No 4 S Direct
Common Stock Acquisiton 2022-05-24 126,126 $103.57 460,959 No 4 M Direct
Common Stock Disposition 2022-05-24 126,126 $140.12 334,833 No 4 S Direct
Common Stock Acquisiton 2022-05-24 156,282 $86.63 491,115 No 4 M Direct
Common Stock Disposition 2022-05-24 156,282 $140.12 334,833 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualifed Stock Option (right to buy) Disposition 2022-05-23 34,898 $103.57 34,898 $103.57
Common Stock Non-Qualifed Stock Option (right to buy) Disposition 2022-05-23 42,568 $86.63 42,568 $86.63
Common Stock Non-Qualifed Stock Option (right to buy) Disposition 2022-05-24 126,126 $103.57 126,126 $103.57
Common Stock Non-Qualifed Stock Option (right to buy) Disposition 2022-05-24 156,282 $86.63 156,282 $86.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
136,163 2028-02-19 No 4 M Direct
171,136 2029-02-18 No 4 M Direct
10,037 2028-02-19 No 4 M Direct
14,854 2029-02-18 No 4 M Direct
Footnotes
  1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $141.11 to $141.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $142.22 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $141.11 to $141.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $142.21 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $140.00 to $140.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021.
  11. The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.